Review





Similar Products

99
Vazyme Biotech Co luciferase reporter assay kit
Luciferase Reporter Assay Kit, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/luciferase reporter assay kit/product/Vazyme Biotech Co
Average 99 stars, based on 1 article reviews
luciferase reporter assay kit - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
Vazyme Biotech Co dual luciferase reporter analysis system kit
Dual Luciferase Reporter Analysis System Kit, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dual luciferase reporter analysis system kit/product/Vazyme Biotech Co
Average 99 stars, based on 1 article reviews
dual luciferase reporter analysis system kit - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
Vazyme Biotech Co dual luciferase reporter assay system
Upregulation of exosomal hsa-miR-3677-3p in dNCR patients and its targeting of ABCB8. A qRT-PCR analysis of hsa-miR-3677-3p levels in plasma-derived exosomes from dNCR patients compared to the control group ( n = 15/group). hsa-miR-3677-3p showed a significant upregulation of 2.236 ± 0.6160-fold change ( p = 0.0011). B Receiver operating characteristic (ROC) curve analysis demonstrating the diagnostic potential of hsa-miR-3677-3p in plasma-derived exosomes from dNCR patients compared to the control group. The area under the curve (AUC) is 0.83 (95% CI: 0.6875–0.9747, p = 0.002). C Schematic representation of <t>the</t> <t>dual-luciferase</t> reporter construct, featuring the SV40 promoter driving firefly luciferase expression, followed by the 3′ UTR of ABCB8 containing predicted binding sites for hsa-miR-3677-3p. D Relative luciferase activity in 293 T cells co-transfected with either the wild-type (WT) or mutant (MUT) 3′-UTR of ABCB8, along with hsa-miR-3677-3p mimics, inhibitors, or controls ( n = 3/group). E qRT-PCR analysis evaluating ABCB8 mRNA expression following the transfection of SH-SY5Y cells with hsa-miR-3677-3p mimics, inhibitors, or negative controls (NC and Inhibitor-NC) ( n = 3/group). Transfection with mimics significantly reduced ABCB8 mRNA levels by 3.05 ± 0.1029-fold change ( p = 0.0046), while inhibitors increased expression by 1.82 ± 0.1595-fold change ( p = 0.0055), compared to their respective negative controls. F Representative images of western blot analysis showing ABCB8 protein levels in SH-SY5Y cells after the transfection of SH-SY5Y cells with hsa-miR-3677-3p mimics, inhibitors, or negative controls (NC and Inhibitor-NC). G Quantification of ABCB8 protein levels from western blot analysis, normalized to β-ACTIN as an internal control ( n = 6/group). Mimic transfection reduced protein expression by 2.28 ± 0.0658-fold ( p < 0.001), whereas inhibitor transfection increased expression by 1.72 ± 0.4141-fold ( p < 0.001), compared to respective controls. Statistical tests: A Student’s t-test; B DeLong’s test for ROC curve comparison; D , E , and G one-way ANOVA with Tukey’s multiple comparisons test. Error bars denote SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001
Dual Luciferase Reporter Assay System, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dual luciferase reporter assay system/product/Vazyme Biotech Co
Average 99 stars, based on 1 article reviews
dual luciferase reporter assay system - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
Vazyme Biotech Co dualluciferase reporter assay system
Upregulation of exosomal hsa-miR-3677-3p in dNCR patients and its targeting of ABCB8. A qRT-PCR analysis of hsa-miR-3677-3p levels in plasma-derived exosomes from dNCR patients compared to the control group ( n = 15/group). hsa-miR-3677-3p showed a significant upregulation of 2.236 ± 0.6160-fold change ( p = 0.0011). B Receiver operating characteristic (ROC) curve analysis demonstrating the diagnostic potential of hsa-miR-3677-3p in plasma-derived exosomes from dNCR patients compared to the control group. The area under the curve (AUC) is 0.83 (95% CI: 0.6875–0.9747, p = 0.002). C Schematic representation of <t>the</t> <t>dual-luciferase</t> reporter construct, featuring the SV40 promoter driving firefly luciferase expression, followed by the 3′ UTR of ABCB8 containing predicted binding sites for hsa-miR-3677-3p. D Relative luciferase activity in 293 T cells co-transfected with either the wild-type (WT) or mutant (MUT) 3′-UTR of ABCB8, along with hsa-miR-3677-3p mimics, inhibitors, or controls ( n = 3/group). E qRT-PCR analysis evaluating ABCB8 mRNA expression following the transfection of SH-SY5Y cells with hsa-miR-3677-3p mimics, inhibitors, or negative controls (NC and Inhibitor-NC) ( n = 3/group). Transfection with mimics significantly reduced ABCB8 mRNA levels by 3.05 ± 0.1029-fold change ( p = 0.0046), while inhibitors increased expression by 1.82 ± 0.1595-fold change ( p = 0.0055), compared to their respective negative controls. F Representative images of western blot analysis showing ABCB8 protein levels in SH-SY5Y cells after the transfection of SH-SY5Y cells with hsa-miR-3677-3p mimics, inhibitors, or negative controls (NC and Inhibitor-NC). G Quantification of ABCB8 protein levels from western blot analysis, normalized to β-ACTIN as an internal control ( n = 6/group). Mimic transfection reduced protein expression by 2.28 ± 0.0658-fold ( p < 0.001), whereas inhibitor transfection increased expression by 1.72 ± 0.4141-fold ( p < 0.001), compared to respective controls. Statistical tests: A Student’s t-test; B DeLong’s test for ROC curve comparison; D , E , and G one-way ANOVA with Tukey’s multiple comparisons test. Error bars denote SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001
Dualluciferase Reporter Assay System, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dualluciferase reporter assay system/product/Vazyme Biotech Co
Average 99 stars, based on 1 article reviews
dualluciferase reporter assay system - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

Image Search Results


Upregulation of exosomal hsa-miR-3677-3p in dNCR patients and its targeting of ABCB8. A qRT-PCR analysis of hsa-miR-3677-3p levels in plasma-derived exosomes from dNCR patients compared to the control group ( n = 15/group). hsa-miR-3677-3p showed a significant upregulation of 2.236 ± 0.6160-fold change ( p = 0.0011). B Receiver operating characteristic (ROC) curve analysis demonstrating the diagnostic potential of hsa-miR-3677-3p in plasma-derived exosomes from dNCR patients compared to the control group. The area under the curve (AUC) is 0.83 (95% CI: 0.6875–0.9747, p = 0.002). C Schematic representation of the dual-luciferase reporter construct, featuring the SV40 promoter driving firefly luciferase expression, followed by the 3′ UTR of ABCB8 containing predicted binding sites for hsa-miR-3677-3p. D Relative luciferase activity in 293 T cells co-transfected with either the wild-type (WT) or mutant (MUT) 3′-UTR of ABCB8, along with hsa-miR-3677-3p mimics, inhibitors, or controls ( n = 3/group). E qRT-PCR analysis evaluating ABCB8 mRNA expression following the transfection of SH-SY5Y cells with hsa-miR-3677-3p mimics, inhibitors, or negative controls (NC and Inhibitor-NC) ( n = 3/group). Transfection with mimics significantly reduced ABCB8 mRNA levels by 3.05 ± 0.1029-fold change ( p = 0.0046), while inhibitors increased expression by 1.82 ± 0.1595-fold change ( p = 0.0055), compared to their respective negative controls. F Representative images of western blot analysis showing ABCB8 protein levels in SH-SY5Y cells after the transfection of SH-SY5Y cells with hsa-miR-3677-3p mimics, inhibitors, or negative controls (NC and Inhibitor-NC). G Quantification of ABCB8 protein levels from western blot analysis, normalized to β-ACTIN as an internal control ( n = 6/group). Mimic transfection reduced protein expression by 2.28 ± 0.0658-fold ( p < 0.001), whereas inhibitor transfection increased expression by 1.72 ± 0.4141-fold ( p < 0.001), compared to respective controls. Statistical tests: A Student’s t-test; B DeLong’s test for ROC curve comparison; D , E , and G one-way ANOVA with Tukey’s multiple comparisons test. Error bars denote SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Journal: Neurochemical Research

Article Title: Plasma-Derived Exosomal hsa-miR-3677-3p Induces Ferroptosis in Neurons by Targeting ABCB8 in Perioperative Neurocognitive Disorders After Prostate Surgery

doi: 10.1007/s11064-026-04665-2

Figure Lengend Snippet: Upregulation of exosomal hsa-miR-3677-3p in dNCR patients and its targeting of ABCB8. A qRT-PCR analysis of hsa-miR-3677-3p levels in plasma-derived exosomes from dNCR patients compared to the control group ( n = 15/group). hsa-miR-3677-3p showed a significant upregulation of 2.236 ± 0.6160-fold change ( p = 0.0011). B Receiver operating characteristic (ROC) curve analysis demonstrating the diagnostic potential of hsa-miR-3677-3p in plasma-derived exosomes from dNCR patients compared to the control group. The area under the curve (AUC) is 0.83 (95% CI: 0.6875–0.9747, p = 0.002). C Schematic representation of the dual-luciferase reporter construct, featuring the SV40 promoter driving firefly luciferase expression, followed by the 3′ UTR of ABCB8 containing predicted binding sites for hsa-miR-3677-3p. D Relative luciferase activity in 293 T cells co-transfected with either the wild-type (WT) or mutant (MUT) 3′-UTR of ABCB8, along with hsa-miR-3677-3p mimics, inhibitors, or controls ( n = 3/group). E qRT-PCR analysis evaluating ABCB8 mRNA expression following the transfection of SH-SY5Y cells with hsa-miR-3677-3p mimics, inhibitors, or negative controls (NC and Inhibitor-NC) ( n = 3/group). Transfection with mimics significantly reduced ABCB8 mRNA levels by 3.05 ± 0.1029-fold change ( p = 0.0046), while inhibitors increased expression by 1.82 ± 0.1595-fold change ( p = 0.0055), compared to their respective negative controls. F Representative images of western blot analysis showing ABCB8 protein levels in SH-SY5Y cells after the transfection of SH-SY5Y cells with hsa-miR-3677-3p mimics, inhibitors, or negative controls (NC and Inhibitor-NC). G Quantification of ABCB8 protein levels from western blot analysis, normalized to β-ACTIN as an internal control ( n = 6/group). Mimic transfection reduced protein expression by 2.28 ± 0.0658-fold ( p < 0.001), whereas inhibitor transfection increased expression by 1.72 ± 0.4141-fold ( p < 0.001), compared to respective controls. Statistical tests: A Student’s t-test; B DeLong’s test for ROC curve comparison; D , E , and G one-way ANOVA with Tukey’s multiple comparisons test. Error bars denote SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Article Snippet: At 24- or 48-hours post-transfection, cells were lysed, and luminescence was quantified using the Dual-Luciferase Reporter Assay System (DL101, Vazyme, China).

Techniques: Quantitative RT-PCR, Clinical Proteomics, Derivative Assay, Control, Diagnostic Assay, Luciferase, Construct, Expressing, Binding Assay, Activity Assay, Transfection, Mutagenesis, Western Blot, Comparison